Journal of Medical Virology,
Год журнала:
2023,
Номер
95(6)
Опубликована: Июнь 1, 2023
Abstract
Recently
emerging
severe
acute
respiratory
syndrome
coronavirus
2
(SARS‐CoV‐2)
Omicron
variants
are
generally
less
pathogenic
than
previous
strains.
However,
elucidating
the
molecular
basis
for
pulmonary
immune
response
alterations
is
challenging
owing
to
virus's
heterogeneous
distribution
within
complex
tissue
structure.
Here,
we
revealed
spatial
transcriptomic
profiles
of
microstructures
at
SARS‐CoV‐2
infection
site
in
nine
cynomolgus
macaques
upon
inoculation
with
Delta
and
variants.
Delta‐
Omicron‐infected
lungs
had
upregulation
genes
involved
inflammation,
cytokine
response,
complement,
cell
damage,
proliferation,
differentiation
pathways.
Depending
on
(alveoli,
bronchioles,
blood
vessels),
there
were
differences
types
significantly
upregulated
each
pathway.
Notably,
a
limited
number
damage
differentially
expressed
between
bronchioles
Omicron‐infection
groups.
These
results
indicated
that
despite
significant
antigenic
shift
SARS‐CoV‐2,
host
mechanisms
induced
by
relatively
consistent,
transcriptional
observed
only
large
airways.
This
study
may
aid
understanding
pathogenesis
developing
clinical
strategy
addressing
dysregulation
identifying
potential
biomarkers
during
Nature Reviews Microbiology,
Год журнала:
2023,
Номер
unknown
Опубликована: Янв. 18, 2023
In
late
2020,
after
circulating
for
almost
a
year
in
the
human
population,
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
exhibited
major
step
change
its
adaptation
to
humans.
These
highly
mutated
forms
of
SARS-CoV-2
had
enhanced
rates
transmission
relative
previous
variants
and
were
termed
'variants
concern'
(VOCs).
Designated
Alpha,
Beta,
Gamma,
Delta
Omicron,
VOCs
emerged
independently
from
one
another,
turn
each
rapidly
became
dominant,
regionally
or
globally,
outcompeting
variants.
The
success
VOC
previously
dominant
variant
was
enabled
by
altered
intrinsic
functional
properties
virus
and,
various
degrees,
changes
antigenicity
conferring
ability
evade
primed
immune
response.
increased
fitness
associated
with
is
result
complex
interplay
biology
context
changing
immunity
due
both
vaccination
prior
infection.
this
Review,
we
summarize
literature
on
transmissibility
variants,
role
mutations
at
furin
spike
cleavage
site
non-spike
proteins,
potential
importance
recombination
success,
evolution
T
cells,
innate
population
immunity.
shows
complicated
relationship
among
antigenicity,
virulence,
which
has
unpredictable
implications
future
trajectory
disease
burden
COVID-19.
Nature Immunology,
Год журнала:
2023,
Номер
24(12), С. 2068 - 2079
Опубликована: Ноя. 2, 2023
Severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
RNA
generally
becomes
undetectable
in
upper
airways
after
a
few
days
or
weeks
postinfection.
Here
we
used
model
of
viral
infection
macaques
to
address
whether
SARS-CoV-2
persists
the
body
and
which
mechanisms
regulate
its
persistence.
Replication-competent
virus
was
detected
bronchioalveolar
lavage
(BAL)
macrophages
beyond
6
months
Viral
propagation
BAL
occurred
from
cell
inhibited
by
interferon-γ
(IFN-γ).
IFN-γ
production
strongest
NKG2r+CD8+
T
cells
NKG2Alo
natural
killer
(NK)
further
increased
NK
spike
protein
stimulation.
However,
impaired
with
persisting
virus.
Moreover,
also
enhanced
expression
major
histocompatibility
complex
(MHC)-E
on
macrophages,
possibly
inhibiting
cell-mediated
killing.
Macaques
less
mounted
adaptive
that
escaped
MHC-E-dependent
inhibition.
Our
findings
reveal
an
interplay
between
regulated
persistence
mediated
IFN-γ.
EBioMedicine,
Год журнала:
2023,
Номер
95, С. 104753 - 104753
Опубликована: Авг. 12, 2023
Among
the
Omicron
sublineages
that
have
emerged,
BA.1,
BA.2,
BA.5,
and
their
related
resulted
in
largest
number
of
infections.
While
recent
studies
demonstrated
all
robustly
escape
neutralizing
antibody
response,
it
remains
unclear
on
whether
these
share
any
pattern
evolutionary
trajectory
replication
efficiency
intrinsic
pathogenicity
along
respiratory
tract.We
compared
virological
features,
capacity
dominant
BA.2
BA.5
human
nasal
epithelium,
characterized
K18-hACE2,
A129,
young
C57BL/6,
aged
C57BL/6
mice.We
found
replicated
most
robustly,
followed
by
differentiated
epithelium.
Consistently,
infection
higher
viral
gene
copies,
infectious
titres
more
abundant
antigen
expression
turbinates
infected
K18-hACE2
transgenic
mice.
In
contrast,
are
continuously
attenuated
lungs
mice,
leading
to
decreased
pathogenicity.
Nevertheless,
lung
manifestations
remain
severe
sublineages-infected
A129
mice.Our
results
suggested
might
be
gaining
fitness
upper
tract,
therefore
highlighting
importance
global
surveillance
emergence
hyper-transmissive
sublineages.
On
contrary,
is
further
lower
tract.
Effective
vaccination
other
precautions
should
place
prevent
infections
immunocompromised
populations
at
risk.A
full
list
funding
bodies
contributed
this
study
can
Acknowledgements
section.
Bratislavské lekárske listy/Bratislava medical journal,
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 30, 2025
Abstract
Background
The
coronavirus
disease
2019
(COVID-19)
has
highly
impacted
everyday
lives
and
healthcare
systems
since
its
spread
across
the
globe.
As
a
result
of
numerous
mutations
in
viral
genome,
several
genetic
variants
sub-variants
have
evolved,
they
differ
various
characteristics,
such
as
infectivity,
transmissibility,
immune
response
human
body.
aim
this
study
was
to
compare
cytokine
levels
plasma
samples
from
patients
with
acute
COVID-19,
infected
either
Delta
or
Omicron
variants.
Methods
This
retrospective
included
80
hospitalized
PCR-confirmed
SARS-CoV-2.
Blood
well
control
subjects
were
collected,
multiplex
assay
performed
determining
48
cytokines
plasma.
Results
50
Delta,
30
variant,
18
subjects.
Severe
critical
course
led
27
significantly
modified
both
COVID-19
compared
However,
12
(GRO-α,
IFN-α2,
IL-1α,
IL-4,
IL-9,
IL-16,
MIF,
MIP-1β,
SDF-1α,
TNF-α,
TNF-β,
TRAIL)
elevated
versus
variant
discrimination
equal
AUC
=
0.876.
Moreover,
vaccination
decreased
GM-CSF,
IL-7,
IL-8
variant.
Conclusions
suggests
that
SARS-CoV-2
affect
differently.
The
periodic
emergence
of
SARS-CoV-2
variants
concern
(VOCs)
with
unpredictable
clinical
severity
and
ability
to
escape
preexisting
immunity
emphasizes
the
continued
need
for
antiviral
interventions.
Two
small
molecule
inhibitors,
molnupiravir
(MK-4482),
a
nucleoside
analog,
nirmatrelvir
(PF-07321332),
3C-like
protease
inhibitor,
have
recently
been
approved
as
monotherapy
use
in
high-risk
patients
COVID-19.
As
preclinical
data
are
only
available
rodent
ferret
models,
here
we
assessed
efficacy
MK-4482
PF-07321332
alone
combination
against
infection
Delta
VOC
rhesus
macaque
COVID-19
model.
Macaques
were
infected
variant
treated
vehicle,
MK-4482,
PF-07321332,
or
PF-07321332.
Clinical
exams
performed
at
1,
2,
4
days
postinfection
assess
disease
virological
parameters.
Notably,
improved
individual
inhibitory
effect
both
drugs,
resulting
milder
progression,
stronger
reduction
virus
shedding
from
mucosal
tissues
upper
respiratory
tract,
viral
replication
lower
reduced
lung
pathology.
Our
strongly
indicate
superiority
combined
treatment
infections
demonstrated
closest
surrogate
model
human
infection.
Molecular Biology and Evolution,
Год журнала:
2023,
Номер
40(9)
Опубликована: Сен. 1, 2023
Abstract
In
viral
evolution,
a
new
mutation
has
to
proliferate
within
the
host
(Stage
I)
in
order
be
transmitted
and
then
compete
population
II).
We
now
analyze
intrahost
single
nucleotide
variants
(iSNVs)
set
of
79
SARS-CoV-2
infected
patients
with
most
transmissions
tracked.
Here,
every
two
measures:
1)
iSNV
frequency
each
individual
Stage
I;
2)
occurrence
among
individuals
ranging
from
1
(private),
2–78
(public),
(global)
occurrences
II.
I,
small
fraction
nonsynonymous
iSNVs
are
sufficiently
advantageous
rise
high
frequency,
often
100%.
However,
such
usually
fail
become
public
mutations.
Thus,
selective
forces
stages
evolution
uncorrelated
and,
possibly,
antagonistic.
For
that
reason,
successful
mutants,
including
many
concern,
have
avoid
being
eliminated
I
when
they
first
emerge.
As
result,
may
not
transmission
advantage
outcompete
dominant
strains
hence,
rare
population.
Few
them
could
manage
slowly
accumulate
mutations
When
do,
would
appear
suddenly
as
six
successive
waves
strains.
conclusion,
gate-keeper,
contravene
long-term
should
heeded
studies.
Science Translational Medicine,
Год журнала:
2023,
Номер
15(711)
Опубликована: Авг. 30, 2023
The
Omicron
variant
continuously
evolves
under
the
humoral
immune
pressure
exerted
by
vaccination
and
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
infection,
resulting
subvariants
display
further
evasion
antibody
escape.
An
engineered
angiotensin-converting
enzyme
(ACE2)
decoy
composed
of
high-affinity
ACE2
an
IgG1
Fc
domain
could
offer
alternative
modality
to
neutralize
SARS-CoV-2.
We
previously
reported
its
broad
spectrum
therapeutic
potential
in
rodent
models.
Here,
we
demonstrate
that
retains
neutralization
activity
against
subvariants,
including
currently
emerging
XBB
BQ.1
strains,
which
completely
evade
antibodies
clinical
use.
SARS-CoV-2,
suboptimal
concentration
neutralizing
drugs,
generated
SARS-CoV-2
mutants
escaping
wild-type
monoclonal
antibodies,
whereas
no
escape
mutant
emerged
decoy.
Furthermore,
inhalation
aerosolized
decoys
improved
outcomes
rodents
infected
with
at
a
20-fold
lower
dose
than
intravenous
administration.
Last,
exhibited
efficacy
for
cynomolgus
macaques
These
results
indicate
this
represents
promising
strategy
overcome
immune-evading
variants
liquid
aerosol
be
considered
as
noninvasive
approach
enhance
COVID-19
treatments.
Communications Biology,
Год журнала:
2024,
Номер
7(1)
Опубликована: Март 15, 2024
Abstract
During
the
Omicron
wave,
previous
variants
such
as
BA.2,
BA.4,
and
BA.5
were
replaced
by
newer
with
additional
mutations
in
spike
protein.
These
variants,
BA.4.6,
BQ.1.1,
XBB,
have
spread
different
countries
degrees
of
success.
Here,
we
evaluated
replicative
ability
pathogenicity
BQ1.1,
XBB
clinical
isolates
male
Syrian
hamsters.
Although
found
no
substantial
differences
weight
change
among
hamsters
infected
these
subvariants,
BQ.1.1
lung
tissue
was
higher
than
that
BA.4.6
BA.5.
Of
note,
lethal
both
female
transgenic
human
ACE2
In
competition
assays,
replicated
better
nasal
turbinate
tissues
previously
BA.2.
results
suggest
subvariants
family
are
still
evolving
should
be
closely
monitored.
Cellular and Molecular Immunology,
Год журнала:
2023,
Номер
21(2), С. 134 - 143
Опубликована: Дек. 25, 2023
Abstract
Numerous
pathogens
can
infect
the
olfactory
tract,
yet
pandemic
caused
by
SARS-CoV-2
has
strongly
emphasized
importance
of
mucosa
as
an
immune
barrier.
Situated
in
nasal
passages,
is
directly
exposed
to
environment
sense
airborne
odorants;
however,
this
also
means
it
serve
a
direct
route
entry
from
outside
world
into
brain.
As
result,
olfactotropic
infections
have
serious
consequences,
including
dysfunction
system,
CNS
invasion,
dissemination
lower
respiratory
and
transmission
between
individuals.
Recent
research
shown
that
distinctive
response
needed
protect
neuronal
mucosal
tissue.
A
better
understanding
innate,
adaptive,
structural
barriers
develop
effective
therapeutics
vaccines
against
microbes
such
SARS-CoV-2.
Here,
we
summarize
ramifications
infection
mucosa,
review
subsequent
response,
discuss
important
areas
future
for
immunity
infectious
disease.
Abstract
The
Omicron
BA.1
variant
of
SARS-CoV-2
displays
an
attenuated
phenotype
in
the
Syrian
hamster
after
intranasal
inoculation.
This
is
characterized
by
reduced
viral
replication
and
lung
pathology
lower
respiratory
tract.
Here,
we
report
that
intratracheal
inoculation
with
recovers
tract
pathogenicity
as
observed
other
lineages.